Company Description
United Therapeutics hopes its products will be in vein. Its intravenous drug Remodulin treats pulmonary hypertension, which affects the blood...
Key United Therapeutics Financials
| Company Type | Public - NASDAQ (GS): UTHR Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $210.9 |
| 2006 Employees | 285 |
More United Therapeutics Financials (11 pages)
Latest United Therapeutics Jobs jobs by Indeed
Competition
Competitive Landscape for Chemicals
Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...
Read more about United Therapeutics's competition across multiple industries
Top United Therapeutics Competitors
Sponsored Links
The Business Directory
United Therapeutics Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman and CEO | Martine A. Rothblatt | Network | E-mail |
| President, COO, and Director | Roger Jeffs | Network | E-mail |
| CFO and Treasurer | John M. Ferrari | Network | E-mail |
More United Therapeutics Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current United Therapeutics News
- TREPROSTINIL TREATMENT FOR INTERSTITIAL LUNG DISEASE AND ASTHMA [PCT Biblio Info] (18 Aug 2008 16:10:00 EDT)
- Briefing.com: Hourly In Play (R) - 23:00 ET [Briefing.com] (11 Aug 2008 23:00:00 EDT)
- Briefing.com: Hourly In Play (R) - 22:00 ET [Briefing.com] (11 Aug 2008 22:00:00 EDT)
Sponsored Opportunity
